Document O1aemwdmGdw26qD7193oz7Mvj

fft-oao/-/37< ail 2-z6_ /ozr ___ <P UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 February 14, 2001 OFFICE OF PREVENTION, PESTICIDES AND TOXIC SUBSTANCES DuPont Haskell Laboratory Attn: Gerald L. Kennedy Director, Applied Toxicology Elkton Road, P.O. Box 50 Newark, DE 19714-0050 SUBJECT: FYI-0101-01378 Dear Mr. Kennedy: FYI-00-001378 FYI-0 0 -0 0 1 3 7 8 Regarding your January 25, 2001, FYI submission on ammonium perfluorooctanoate, please explain your rationale for reporting the results in this submission, as well as in your earlier submission of June 23, 2000, as voluntary FYI submissions rather than under TSCA Section 8(e). In particular, the results of the human blood serum tests for ammonium perfluorooctane, in combination with possible human health hazard concerns, indicate that these results should have been considered for reporting under the Section 8(e) requirements of TSCA. Enclosed is the first page of your submission and a copy of "Support Information for Confidentiality Claims". Please cite the assigned FYI number and address your response to: Document Control Office (7407) Room G99 East Tower ATTN: FYI Office of Pollution Prevention and Toxics U.S. Environmental Protection Agency 401 M Street, S.W. Washington, D.C. 20460-0001 c cr . c- <r High Production Volume Chemicals Branch Enclosures 85010000005 85010000005 Internet Address (URL) http://www.epa.gov Recycled/Recyclable Printed with Vegetable Oil Based Inks on Recycled Paper (Minimum 25% Postconsumer)